In order to bring you the best possible user experience, this site uses Javascript. If you are seeing this message, it is likely that the Javascript option in your browser is disabled. For optimal viewing of this site, please ensure that Javascript is enabled for your browser.

This content is currently on FREE ACCESS, enjoy another 18 days of free consultation

In these unprecedented times, the ESC is doing everything it can to support its community: FREE access to all ESC 365 content until 31 July: explore more than 125,000 educational resources.

From 1 August onwards, support our mission by becoming a member.

How mHealth apps improves access to cardiovascular care in Mainland China?

Session Digital health in clinical practice

Speaker Jeffrey Hsu

Event : ESC Congress 2018

  • Topic : e-cardiology / digital health, public health, health economics, research methodology
  • Sub-topic : m-Health
  • Session type : Rapid Fire Abstracts

Authors : J Hsu (Beijing,CN), FF Wang (Beijing,CN), FW Jia (Beijing,CN), XH Liu (Beijing,CN), Y Lv (Beijing,CN), W Chen (Beijing,CN)

J. Hsu1 , F.F. Wang1 , F.W. Jia1 , X.H. Liu1 , Y. Lv1 , W. Chen1 , 1Peking Union Medical College Hospital, Cardiology Department - Beijing - China People's Republic of ,

European Heart Journal ( 2018 ) 39 ( Supplement ), 227

Background: Difficult access to healthcare in Mainland China has been documented for many years and places a severe burden on the population. The Chinese Government has taken many initiatives to tackle difficult access such as implementing universal health insurance, and introducing hospital networks for easier referrals to elite hospitals. mHealth services are another modality to improve healthcare access in China. Recently, an overview of mHealth apps in China reported that the most common service among apps targeted access to medical care. The purpose of this study is to examine how mHealth apps and services improve access to cardiovascular care in Mainland China.

Methods: mHealth services with the keywords “appointment making” (in Chinese) were sampled from the major app stores in Mainland China in October 2017. This study included mHealth services provided by hospitals that included cardiovascular care in Mainland China. For each mHealth service we also examined the hospital's location, hospital ranking (as issued by the Chinese Ministry of Health), ability to select specific physicians, online payment availability, and presence of patient identity verification. Standard descriptive statistics was used.

Results: There were 437 hospitals throughout Mainland China offering appointment making through mHealth services, of which 309 hospitals' mHealth service were in operation. 229 hospitals were considered level 3A (highest rating), accounting for nearly 20% of all 3A hospitals in the country. The majority of the hospitals were located in major cities such as Beijing, Shanghai, Guangzhou and Chongqing. We also found that in additional to appointment making, nearly all the apps provided online payments, the ability to select specific doctors, and patient identity verification.

Conclusions: The universality and abundance of mHealth apps and services can provide the Chinese population a more convenient way to access cardiovascular care. Further review of usage rates, especially in rural areas and among the elderly is important to understand the impact of mHealth on access to medical care

Hospitals with mHealth services

Based on your interests

Members get more

Join now
  • 1ESC Professional Members – access all resources from general ESC events 
  • 2ESC Association Members (Ivory, Silver, Gold) – access your Association’s resources
  • 3Under 40 or in training - with a Combined Membership, access all resources
Join now

Our sponsors

ESC 365 is supported by Bayer, Boehringer Ingelheim and Lilly Alliance, Bristol-Myers Squibb and Pfizer Alliance, Novartis Pharma AG and Vifor Pharma in the form of educational grants. The sponsors were not involved in the development of this platform and had no influence on its content.

logo esc

Our mission: To reduce the burden of cardiovascular disease

Who we are